1. Neuroendovascular Optical Coherence Tomography Imaging for Cerebrovascular Disease: Current Concepts and Clinical Potential

   • M. S. Mathews
   • M. E. Linskey

   Invited Commentary 30 August 2012 Pages: 647 - 650

   

2. What Is the Ideal Blood Pressure Goal for Patients with Diabetes Mellitus and Nephropathy?

   • Mark L. Lipman
   • Ernesto L. Schiffrin

   Hypertension (MJ Sorrentino, Section Editor) 18 August 2012 Pages: 651 - 659

3. Should African Americans Have a Lower Blood Pressure Goal than Other Ethnic Groups to Prevent Organ Damage?

   • John M. Flack
   • Tochukwi Okwuosa
   • Phillip Levy

   Hypertension (MJ Sorrentino, Section Editor) 11 October 2012 Pages: 660 - 666

4. Hypertensive Goals in Patients with Coronary Artery Disease

   • Ryan T. Cunnane
   • George L. Bakris

   Hypertension (MJ Sorrentino, Section Editor) 14 August 2012 Pages: 667 - 672

5. Which Diuretic Is the Preferred Agent for Treating Essential Hypertension: Hydrochlorothiazide or Chlorthalidone?

   • F. Wilford Germino

   Hypertension (MJ Sorrentino, Section Editor) 24 August 2012 Pages: 673 - 677

6. White Coat Hypertension: Addressing the 10 Most Important Questions

   • Louis Kuritzky

   Hypertension (MJ Sorrentino, Section Editor) 02 September 2012 Pages: 678 - 683

   

7. Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?

   • Daniel B. Larach
   • Emil M. deGoma
   • Daniel J. Rader

   Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 19 September 2012 Pages: 684 - 691

8. Treatment Targets in the Management of Dyslipidemias: Which Targets in Whom?

   • Scott M. Grundy

   Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 06 September 2012 Pages: 692 - 700

9. Diet and Cardiovascular Disease

   • W. M. Monique Verschuren

   Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 12 October 2012 Pages: 701 - 708

   

10. Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality

    • Ian Graham
    • Marie-Therese Cooney
    • Zeljko Reiner

    Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 11 September 2012 Pages: 709 - 720

    

11. Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes

    • Niina Matikainen
    • Marja-Riitta Taskinen

    Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 02 September 2012 Pages: 721 - 731

    

12. The Dementia of Cardiac Disease

    • Hurmina Muqtadar
    • Fernando D. Testai
    • Philip B. Gorelick

    Stroke (C Sila, Section Editor) 12 September 2012 Pages: 732 - 740

13. Advanced Neuroimaging to Guide Acute Stroke Therapy

    • Gurpreet Singh Sandhu
    • Jeffrey L. Sunshine

    Stroke (C Sila, Section Editor) 22 September 2012 Pages: 741 - 753

    

14. Thrombolytic Evacuation of Intracerebral and Intraventricular Hemorrhage

    • Mahua Dey
    • Agnieszka Stadnik
    • Issam A. Awad

    Stroke (C Sila, Section Editor) 04 September 2012 Pages: 754 - 760

    

15. Challenges in Acute Ischemic Stroke Clinical Trials

    • Anthony J. Furlan

    Stroke (C Sila, Section Editor) 26 August 2012 Pages: 761 - 766